These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1349164)

  • 1. p53 mutations in spontaneously immortalized 3T12 but not 3T3 mouse embryo cells.
    Rittling SR; Denhardt DT
    Oncogene; 1992 May; 7(5):935-42. PubMed ID: 1349164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 mutations in bladder carcinoma cell lines.
    Cooper MJ; Haluschak JJ; Johnson D; Schwartz S; Morrison LJ; Lippa M; Hatzivassiliou G; Tan J
    Oncol Res; 1994; 6(12):569-79. PubMed ID: 7787250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth suppression of normal mammary epithelial cells by wild-type p53.
    Merlo GR; Venesio T; Taverna D; Marte BM; Callahan R; Hynes NE
    Oncogene; 1994 Feb; 9(2):443-53. PubMed ID: 8290256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
    Zhang DL; Ji L; Li YD
    Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation.
    Albor A; Flessate DM; Soussi T; Notario V
    Cancer Res; 1994 Aug; 54(16):4502-7. PubMed ID: 8044802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression.
    Ruggeri B; Caamano J; Goodrow T; DiRado M; Bianchi A; Trono D; Conti CJ; Klein-Szanto AJ
    Cancer Res; 1991 Dec; 51(24):6615-21. PubMed ID: 1742735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
    Lansing TJ; Turk BF; Kanner SB; Gilmer TM
    Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer.
    Hensel CH; Xiang RH; Sakaguchi AY; Naylor SL
    Oncogene; 1991 Jun; 6(6):1067-71. PubMed ID: 1648702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes.
    Ruggeri B; Zhang SY; Caamano J; DiRado M; Flynn SD; Klein-Szanto AJ
    Oncogene; 1992 Aug; 7(8):1503-11. PubMed ID: 1630814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro.
    Ozbun MA; Jerry DJ; Kittrell FS; Medina D; Butel JS
    Cancer Res; 1993 Apr; 53(7):1646-52. PubMed ID: 8453637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The properties of p53 proteins selected for the loss of suppression of transformation.
    Olson DC; Levine AJ
    Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes.
    Sakai E; Tsuchida N
    Oncogene; 1992 May; 7(5):927-33. PubMed ID: 1570156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic characterization of the lysophosphatidic acid receptor gene, lp(A2)/Edg4, and identification of a frameshift mutation in a previously characterized cDNA.
    Contos JJ; Chun J
    Genomics; 2000 Mar; 64(2):155-69. PubMed ID: 10729222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog.
    Van Leeuwen IS; Hellmèn E; Cornelisse CJ; Van den Burgh B; Rutteman GR
    Anticancer Res; 1996; 16(6B):3737-44. PubMed ID: 9042250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines.
    Reiss M; Brash DE; Muñoz-Antonia T; Simon JA; Ziegler A; Vellucci VF; Zhou ZL
    Oncol Res; 1992; 4(8-9):349-57. PubMed ID: 1486218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organization of the murine Cd22 locus. Mapping to chromosome 7 and characterization of two alleles.
    Law CL; Torres RM; Sundberg HA; Parkhouse RM; Brannan CI; Copeland NG; Jenkins NA; Clark EA
    J Immunol; 1993 Jul; 151(1):175-87. PubMed ID: 8100843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment of mouse p53 yeast functional assay and evaluation of its detectability of p53 gene mutation].
    Tsunematsu I
    Hokkaido Igaku Zasshi; 1999 Jul; 74(4):301-14. PubMed ID: 10480037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency.
    Tiemann F; Deppert W
    Oncogene; 1994 Jul; 9(7):1907-15. PubMed ID: 8208537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.